Philip Morris operations and economic impact in Europe

Philip Morris International (PMI) has demonstrated a complex economic and operational presence in Europe. In the first half of 2026, the company reported varied financial outcomes across specific regional markets. In Serbia, revenues increased to 20.7 billion dinars, though net profit fell to 3.7 billion dinars due to rising operating expenses. In the Czech Republic, net profit dropped by 7.2% to 1.49 billion CZK, driven by declining traditional cigarette volumes and unfavorable exchange rates, despite growth in the smokeless category. The company also noted a decline in market share in both the Czech Republic (39.6%) and Slovakia (48.9%).

An EY-Parthenon study detailed PMI’s economic footprint in the European Union between 2021 and 2025, noting a contribution of nearly €343 billion. This includes €22.3 billion spent with European suppliers, €27.4 billion invested in European operations, and €39.5 billion in exports. In Germany, the company reported €7.4 billion in spending and investments, including €4.8 billion directed toward German suppliers. The company’s activities supported approximately 164,000 jobs in 2025.

As part of a long-term corporate strategy, PMI is transitioning from traditional tobacco to alternative products. By the third quarter of 2026, smoke-free products, including IQOS, VEEV, and ZYN, surpassed 40% of total net revenues across 110 markets. Globally, net revenue rose 5.5% to $11.44 billion in Q3 2026. This transition is supported by over $16 billion in global R&D investments since 2008. However, the company noted decelerating growth for ZYN in the United States and rising cost pressures stemming from geopolitical tensions in the Middle East and operational disruptions in Ukraine.